Title: Budesonide: A promising candidate therapeutic for early COVID-19
| dc.contributor.author | Shailesh Kumar Patel | |
| dc.contributor.author | Rakesh Kumar | |
| dc.contributor.author | Jigyasa Rana | |
| dc.contributor.author | Aditya Agrawal | |
| dc.contributor.author | Alok Singh | |
| dc.contributor.author | Adesh Kumar | |
| dc.date.accessioned | 2026-02-07T10:39:02Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | [No abstract available] | |
| dc.identifier.doi | 10.1016/j.amsu.2021.102605 | |
| dc.identifier.issn | 20490801 | |
| dc.identifier.uri | https://doi.org/10.1016/j.amsu.2021.102605 | |
| dc.identifier.uri | https://dl.bhu.ac.in/bhuir/handle/123456789/37423 | |
| dc.publisher | Elsevier Ltd | |
| dc.subject | Budesonide | |
| dc.subject | Clinical trial | |
| dc.subject | Corticosteroid | |
| dc.subject | COVID-19 | |
| dc.subject | Drug | |
| dc.subject | Inhaled | |
| dc.title | Budesonide: A promising candidate therapeutic for early COVID-19 | |
| dc.type | Publication | |
| dspace.entity.type | Letter |
